RGC (Regencell Bioscience Holdings) Days Sales Outstanding: (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RGC Regencell Bioscience Holdings Ltd RGC
30 GF Score
Price $5.92
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings Days Sales Outstanding?

Regencell Bioscience Holdings's average Accounts Receivable for the six months ended in Dec. 2025 was $0.00 Mil. Regencell Bioscience Holdings's Revenue for the six months ended in Dec. 2025 was $0.00 Mil.

The historical rank and industry rank for Regencell Bioscience Holdings's Days Sales Outstanding or its related term are showing as below:

RGC's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 71.98
* Ranked among companies with meaningful Days Sales Outstanding only.

Regencell Bioscience Holdings's Days Sales Outstanding stayed the same from Dec. 2024 () to Dec. 2025 ().

Regencell Bioscience Holdings  (NAS:RGC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Regencell Bioscience Holdings Days Sales Outstanding Related Terms

Regencell Bioscience Holdings Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Days Sales Outstanding Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Days Sales Outstanding
Get a 7-Day Free Trial - - - - -

Regencell Bioscience Holdings Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only - - - - -

RGC vs SUPN, BCRX, PBH: Days Sales Outstanding Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings Days Sales Outstanding vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Days Sales Outstanding falls into.


RGC
30GF Score
Regencell Bioscience Holdings Ltd RGC
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regencell Bioscience Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Regencell Bioscience Holdings's Days Sales Outstanding for the fiscal year that ended in Jun. 2025 is calculated as

Days Sales Outstanding (A: Jun. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Jun. 2025 )) / count ) / Revenue (A: Jun. 2025 )*Days in Period
=( ( + ) / 1 ) / 0*365
=0 / 0*365
=N/A

Regencell Bioscience Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding (Q: Dec. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2025 ) + Accounts Receivable (A: Dec. 2025 )) / count ) / Revenue (A: Dec. 2025 )*Days in Period
=( ( + ) / 1 ) / 0*365 / 2
=0 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
30GF Score

Get the complete analysis for RGC

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.92
Price